Deals
Merck buys rights to NewLink's experimental Ebola vaccine
Merck & Co Inc (MRK.N) on Monday said it would buy worldwide commercial rights to NewLink Genetics Corp's (NLNK.O) experimental vaccine against the Ebola virus.
Ackman's Pershing Square sees big payoff from Allergan deal
Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc., his firm's biggest bet of 2014.
EE owners confirm takeover talks with BT
EE's German and French owners confirmed on Wednesday they were in talks to sell Britain's biggest mobile network operator to BT (BT.L) as part of a wider review of its options. Fixed-line operator BT said on Monday it was in talks with both Telefonica's (TEF.MC) O2 and a rival operator about buying a mobile business.
U.S. buyout firm Carlyle enters South Africa with tyre deal
Carlyle Group (CG.O) has agreed to buy South African tyre retailer Tiger Automotive from Ethos Private Equity, Ethos said on Wednesday, the U.S. buyout firm's first deal in Africa's most developed economy.




